Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 1/2 1

Status

Terminated 2Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Plasma cell 1

Conditions

Fatigue 21Neoplasms 6cyclopia sequence 4Glioma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Sleepiness 2Sleep Initiation and Maintenance Disorders 2Pain 2Lung Neoplasms 2Head and Neck Neoplasms 2Breast Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Sleep Wake Disorders 1Prostatic Neoplasms 1Parasomnias 1Oligodendroglioma 1Neurotoxicity Syndromes 1Nervous System Neoplasms 1Multiple Myeloma 1Meningioma 1Melanoma 1Lymphoma, B-Cell 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Laryngeal Diseases 1Gliosarcoma 1Glioma, Subependymal 1Glioblastoma 1Esophageal Neoplasms 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 92Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 52Doxorubicin 50trametinib 47atezolizumab 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Modafinil × Clear all
NCT05333250 2026-01-13

MODIFY

Ottawa Hospital Research Institute

Phase 1/2 Recruiting
40 enrolled

Fatigue, Neoplasms, Cognitive Dysfunction

NCT00267332 2018-05-07

Modafinil in Opioid Induced Sedation

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 3 Terminated
90 enrolled

Neoplasms, Pain

NCT00825227 2017-11-17

Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Terminated
10 enrolled 7 charts

Fatigue, Neoplasms

NCT00178373 2015-12-23

Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer

University of Rochester

Phase 2 Completed
96 enrolled

Fatigue, Neoplasms

NCT01160380 2014-11-06

A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma

Oncotherapeutics

Phase 3 Completed
50 enrolled 14 charts
Plasma cell

Fatigue, Multiple Myeloma, Neoplasms

NCT01766323 2013-01-11

Palliative Morphine With or Without Concurrent Modafinil

Dr. Rajendra Prasad Government Medical College

Phase 3 Unknown
200 enrolled

Sleepiness, Disorders of Excessive Somnolence, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡